{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:37:02Z","timestamp":1781152622016,"version":"3.54.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.parkreldis.2015.05.025","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T11:47:15Z","timestamp":1433504835000},"page":"929-937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["The contribution of cerebellar proton magnetic resonance spectroscopy in the differential diagnosis among parkinsonian syndromes"],"prefix":"10.1016","volume":"21","author":[{"given":"Stefano","family":"Zanigni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Testa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Calandra-Buonaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Sambati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Guarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gabellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Evangelisti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3633-8818","authenticated-orcid":false,"given":"Pietro","family":"Cortelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Lodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Tonon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2015.05.025_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease","volume":"56","author":"Gelb","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib2","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1212\/WNL.46.4.922","article-title":"Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)","volume":"46","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuint.2013.06.005","article-title":"Biomarkers in Parkinson's disease (recent update)","volume":"63","author":"Sharma","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000314495","article-title":"Significance of MRI in diagnosis and differential diagnosis of Parkinson's disease","volume":"7","author":"Mahlknecht","year":"2010","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib6","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2967\/jnumed.108.059998","article-title":"Imaging approaches to Parkinson disease","volume":"51","author":"Brooks","year":"2010","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib7","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/mds.24968","article-title":"Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy","volume":"27","author":"Massey","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11910-013-0400-1","article-title":"The evolving role of diffusion magnetic resonance imaging in movement disorders","volume":"13","author":"Hess","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib9","first-page":"75","article-title":"Magnetic resonance spectroscopy in Parkinson's disease and parkinsonian syndromes","volume":"22","author":"Rango","year":"2007","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib10","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1148\/radiol.13130531","article-title":"Clinical proton MR spectroscopy in central nervous system disorders","volume":"270","author":"Oz","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib11","first-page":"61","article-title":"Proton MR spectroscopy of the brain in 14 patients with Parkinson disease","volume":"16","author":"Bowen","year":"1995","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ana.410370211","article-title":"Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy","volume":"37","author":"Davie","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib13","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/jnnp.58.6.688","article-title":"Magnetic resonance spectroscopic study of parkinsonism related to boxing","volume":"58","author":"Davie","year":"1995","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/mrm.1910330502","article-title":"Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study","volume":"33","author":"Holshouser","year":"1995","journal-title":"Magn. Reson Med."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/1353-8020(96)00007-7","article-title":"Proton magnetic resonance spectroscopy of the striatum in Parkinson's disease patients with motor response fluctuations","volume":"2","author":"Chaudhuri","year":"1996","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mds.870120306","article-title":"Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy","volume":"12","author":"Clarke","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0730-725X(97)00079-9","article-title":"Proton MR spectroscopic imaging of the striatum in Parkinson's disease","volume":"15","author":"Cruz","year":"1997","journal-title":"Magn. Reson Imaging"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib18","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/mds.870120525","article-title":"Proton magnetic resonance spectroscopy in Steele-Richardson-Olszewski syndrome","volume":"12","author":"Davie","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib19","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1212\/WNL.49.2.438","article-title":"Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study","volume":"49","author":"Ellis","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/jnnp.62.3.239","article-title":"Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy","volume":"62","author":"Federico","year":"1997","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib21","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/mds.870120611","article-title":"Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders","volume":"12","author":"Federico","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib22","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/brain\/120.9.1541","article-title":"Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration","volume":"120","author":"Tedeschi","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00004424-199808000-00005","article-title":"Neuronal laterality in Parkinson's disease with unilateral symptom by in\u00a0vivo 1H magnetic resonance spectroscopy","volume":"33","author":"Choe","year":"1998","journal-title":"Invest Radiol."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib24","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1212\/WNL.50.4.1033","article-title":"Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases","volume":"50","author":"Hoang","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s100720050035","article-title":"Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes","volume":"20","author":"Federico","year":"1999","journal-title":"Ital. J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/jnnp.67.1.20","article-title":"Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: a proton MR spectroscopy study","volume":"67","author":"Hu","year":"1999","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1023\/A:1020609530444","article-title":"A\u00a0proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease","volume":"14","author":"Taylor-Robinson","year":"1999","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib28","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0361-9230(00)00321-X","article-title":"Proton magnetic resonance spectroscopy of patients with parkinsonism","volume":"52","author":"Abe","year":"2000","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib29","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1468-1331.2000.00111.x","article-title":"Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy","volume":"7","author":"Clarke","year":"2000","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s100720170051","article-title":"Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients","volume":"22","author":"Lucetti","year":"2001","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib31","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/mds.10214","article-title":"Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease","volume":"17","author":"O'Neill","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neulet.2003.09.076","article-title":"Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia","volume":"354","author":"Camicioli","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib33","first-page":"103","article-title":"Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA\/Cr reduction in pontine base as a valuable diagnostic marker","volume":"75","author":"Watanabe","year":"2004","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib34","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/mds.21288","article-title":"Magnetic resonance spectroscopic evidence for presupplementary motor area neuronal dysfunction in Parkinson's disease","volume":"22","author":"Camicioli","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib35","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/nbm.1203","article-title":"Reduced brain glutamate in patients with Parkinson's disease","volume":"21","author":"Griffith","year":"2008","journal-title":"NMR Biomed."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S0004-282X2009000100002","article-title":"Neuroimaging in Parkinsonism: a study with magnetic resonance and spectroscopy as tools in the differential diagnosis","volume":"67","author":"Vasconcellos","year":"2009","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib37","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1468-1331.2010.03010.x","article-title":"Quantitative magnetic resonance spectroscopic imaging in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy","volume":"17","author":"Guevara","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib38","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1093\/brain\/awq162","article-title":"Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy","volume":"133","author":"Leh\u00e9ricy","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib39","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/mds.23550","article-title":"Brainstem metabolites in multiple system atrophy of cerebellar type: 3.0-T magnetic resonance spectroscopy study","volume":"26","author":"Takado","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib40","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/jnnp-2012-302699","article-title":"Differentiation between idiopathic and atypical parkinsonian syndromes using three-dimensional magnetic resonance spectroscopic imaging","volume":"84","author":"Gr\u00f6ger","year":"2013","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib41","doi-asserted-by":"crossref","first-page":"e84081","DOI":"10.1371\/journal.pone.0084081","article-title":"Dopamine reduction in the substantia nigra of Parkinson's disease patients confirmed by in\u00a0vivo magnetic resonance spectroscopic imaging","volume":"9","author":"Gr\u00f6ger","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1552-6569.2012.00733.x","article-title":"Whole-brain proton MR spectroscopic imaging in Parkinson's disease","volume":"24","author":"Levin","year":"2014","journal-title":"J.\u00a0Neuroimaging"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11682-013-9251-2","article-title":"Application of proton magnetic resonance spectroscopy on substantia nigra metabolites in Parkinson's disease","volume":"8","author":"Zhou","year":"2014","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib44","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/mds.25015","article-title":"Magnetic resonance imaging of the substantia nigra in Parkinson's disease","volume":"27","author":"Leh\u00e9ricy","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib45","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/brain\/aws360","article-title":"The cerebellum in Parkinson's disease","volume":"136","author":"Wu","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib46","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1148\/radiol.2453061703","article-title":"MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy","volume":"246","author":"Quattrone","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib47","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/brain\/awn195","article-title":"Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease","volume":"131","author":"Rizzo","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib48","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/WCO.0b013e32833be924","article-title":"Neuropathology of variants of progressive supranuclear palsy","volume":"23","author":"Dickson","year":"2010","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib49","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-011-0852-9","article-title":"Neuropathology underlying clinical variability in patients with synucleinopathies","volume":"122","author":"Halliday","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib50","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1148\/radiol.12120364","article-title":"Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease","volume":"267","author":"Nicoletti","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib51","first-page":"289","article-title":"Proton magnetic resonance spectroscopy and single photon emission CT in patients with olivopontocerebellar atrophy","volume":"38","author":"Ikuta","year":"1998","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib52","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1148\/radiol.2232010722","article-title":"Proton MR spectroscopy of the cerebellum and pons in patients with degenerative ataxia","volume":"223","author":"Mascalchi","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib53","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.parkreldis.2004.02.006","article-title":"Characterization of ataxias with magnetic resonance imaging and spectroscopy","volume":"10","author":"Viau","year":"2004","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib54","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/jmri.20846","article-title":"Differentiation of SCA2 from MSA-C using proton magnetic resonance spectroscopic imaging","volume":"25","author":"Boesch","year":"2007","journal-title":"J.\u00a0Magn. Reson Imaging"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib55","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12311-010-0213-6","article-title":"Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy","volume":"10","author":"Oz","year":"2011","journal-title":"Cerebellum"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib56","doi-asserted-by":"crossref","first-page":"e47925","DOI":"10.1371\/journal.pone.0047925","article-title":"Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar type on proton magnetic resonance spectroscopy","volume":"7","author":"Lirng","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib57","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/brain\/awh488","article-title":"Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism","volume":"128","author":"Williams","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib58","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1093\/brain\/awp210","article-title":"Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study","volume":"132","author":"Lodi","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib59","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mrm.1910300604","article-title":"Estimation of metabolite concentrations from localized in\u00a0vivo proton NMR spectra","volume":"30","author":"Provencher","year":"1993","journal-title":"Magn. Reson Med."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib60","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/nbm.698","article-title":"Automatic quantitation of localized in\u00a0vivo 1H spectra with LCModel","volume":"14","author":"Provencher","year":"2001","journal-title":"NMR Biomed."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib61","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/jon.12074","article-title":"Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson's disease","volume":"25","author":"Weiduschat","year":"2013","journal-title":"J.\u00a0Neuroimaging"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib62","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1148\/radiol.2393050459","article-title":"MR imaging of middle cerebellar peduncle width: differentiation of multiple system atrophy from Parkinson disease","volume":"239","author":"Nicoletti","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib63","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/brain\/awl166","article-title":"Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy","volume":"129","author":"Nicoletti","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2015.05.025_bib64","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1002\/mds.22279","article-title":"Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease","volume":"23","author":"Nicoletti","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.05.025_bib65","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1093\/brain\/awh303","article-title":"The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations","volume":"127","author":"Ozawa","year":"2004","journal-title":"Brain"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802015002436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802015002436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T00:52:34Z","timestamp":1537577554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802015002436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1353802015002436"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2015.05.025","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The contribution of cerebellar proton magnetic resonance spectroscopy in the differential diagnosis among parkinsonian syndromes","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2015.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}